OsteoSee

Company Overview

Snapshot

Founded in December 2017 by Ze'ev Weinfeld and Shimon Abboud (Arad), OsteoSee operates with 1–10 employees. The company has secured funding across one round from eHealth Ventures. OsteoSee ceased operations in January 2022.

Business overview

OsteoSee is a clinical-stage company developing a comprehensive solution for bone health screening and monitoring. The company utilizes proprietary parametric electrical impedance tomography (pEIT) technology to provide rapid diagnosis and frequent monitoring of bone mineral density (BMD) via the wrist or pelvis. Its product offerings include OsteoSee Clinic, a tabletop system for primary care physicians, and OsteoSee Home, a wristband system connected to a smartphone for remote and self-monitoring. OsteoSee addresses the unmet need for point-of-care screening and diagnosis of osteopenia and osteoporosis in primary care clinics and homes, operating within the Health Tech & Life Sciences sector, specifically in Digital Healthcare and Medical Devices.

Company Intelligence Q&A

What is OsteoSee's primary focus?

OsteoSee is focused on bringing bone-health screening and monitoring solutions to primary care clinics and homes, utilizing proprietary parametric electrical impedance tomography (pEIT) technology.

When was OsteoSee founded?

OsteoSee was founded in December 2017.

Who are the founders of OsteoSee?

OsteoSee was co-founded by Ze'ev Weinfeld and Shimon Abboud (Arad).

What is the status of OsteoSee?

OsteoSee is currently non-active and ceased to operate in January 2022.

What technology does OsteoSee use for bone health screening?

OsteoSee uses proprietary parametric electrical impedance tomography (pEIT) technology to provide bone mineral density (BMD) measurements.